Weaver R D, Gerbi B J, Dusenbery K E
University of Minnesota Hospital and Clinics, Department of Therapeutic Radiology, Radiation Oncology, Minneapolis, USA.
Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):475-8. doi: 10.1016/0360-3016(95)00161-Q.
To determine acceptable dose variation using thermoluminescent dosimeters (TLD) in the treatment of Mycosis Fungoides with total skin electron beam (TSEB) irradiation.
From 1983 to 1993, 22 patients were treated with total skin electron beam therapy in the standing position. A six-field technique was used to deliver 2 Gy in two days, treating 4 days per week, to a total dose of 35 to 40 Gy using a degraded 9 MeV electron beam. Thermoluminescent dosimeters were placed on several locations of the body and the results recorded. The variations in these readings were analyzed to determine normal dose variation for various body locations during TSEB.
The dose to flat surfaces of the body was essentially the same as the dose to the prescription point. The dose to tangential surfaces was within +/- 10% of the prescription dose, but the readings showed much more variation (up to 24%). Thin areas of the body showed large deviations from the prescription dose along with a large amount of variation in the readings (up to 22%). Special areas of the body, such as the perineum and eyelid, showed large deviations from the prescription dose with very large (up to 40%) variations in the readings.
The TLD results of this study will be used as a quality assurance check for all new patients treated with TSEB. The results of the TLDs will be compared with this baseline study to determine if the delivered dose is within acceptable ranges. If the TLD results fall outside the acceptable limits established above, then the patient position can be modified or the technique itself evaluated.
使用热释光剂量计(TLD)确定在蕈样肉芽肿全皮肤电子束(TSEB)照射治疗中的可接受剂量变化。
1983年至1993年,22例患者在站立位接受全皮肤电子束治疗。采用六野技术,在两天内给予2 Gy,每周治疗4天,使用9 MeV能量降解电子束,总剂量为35至40 Gy。将热释光剂量计放置在身体的几个部位并记录结果。分析这些读数的变化,以确定TSEB治疗期间不同身体部位的正常剂量变化。
身体平坦表面的剂量与处方点的剂量基本相同。切线表面的剂量在处方剂量的±10%范围内,但读数显示出更大的变化(高达24%)。身体较薄部位与处方剂量有较大偏差,读数变化也很大(高达22%)。身体的特殊部位,如会阴和眼睑,与处方剂量有较大偏差,读数变化非常大(高达40%)。
本研究的TLD结果将用作所有接受TSEB治疗的新患者的质量保证检查。TLD的结果将与本基线研究进行比较,以确定所给予的剂量是否在可接受范围内。如果TLD结果超出上述可接受限度,则可调整患者体位或评估技术本身。